Press Room Archive - Bionical Emas

FEATURED

Bionical Emas to establish European storage, distribution and labelling facility in Co. Westmeath

Download here

Press Release

About Bionical Emas

Bionical Emas is the only Contract Research Organization that combines Clinical Development, Clinical Trial Supply (CTS) and Early Access Programs (EAP) to deliver a unique, seamless approach to bring life-changing medicines to patients around the world.

Learn more

News

Press Release

Resource

Press Release

Resource

Press Release

Resource

Press Release

1 / 3

Press

Bionical Emas to establish European storage, distribution and labelling facility in Co. Westmeath

Press Release

About Bionical Emas

The Guardian - Inviting patients as equal partners in the drug development process

News

Tom Watson appointed Chief Executive Officer

Press Release

Carl Hvass appointed Chief Financial Officer

Press Release

Medics 4 Rare Diseases - The Rare Disease Podcast 4 Medics

Resource

Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia

Resource

Amylyx Pharmaceuticals Announces Launch of U.S. Expanded Access Program for AMX0035

Press Release

Webinar: Operationalize Expanded Access Programs

Resource

Webinar: The International Rare Disease Showcase

Resource

Bionical Emas to establish European storage, distribution and labelling facility in Co. Westmeath

Press Release

Janssen Guide to Expanded Access

Resource

What is an Early Access Program?

Resource

Bionical Emas launches Expanded Access Program for JZP458 – a recombinant Erwinia Asparaginase

Press Release

How else can we help?

Clinical Development

Clinical Trial Supply

Early Access Programs